Chemed Corporation Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2025: 26.03%

Chemed Corporation Return on Equity (ROE) is 26.03% for the Trailing 12 Months (TTM) ending March 31, 2025, a -2.11% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.
  • Chemed Corporation Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2024 was 26.59%, a -14.38% change year over year.
  • Chemed Corporation Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2023 was 31.06%, a -14.58% change year over year.
  • Chemed Corporation Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2022 was 36.36%, a -6.54% change year over year.
  • Chemed Corporation Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2021 was 38.91%, a 13.67% change year over year.
Key Data
Date Return on Equity (ROE) Return on Assets (ROA) Revenue Per Share Free Cash Flow Per Share